Hem › Huvud- och halscancer › Illinois › Chicago
Kliniska studier för Huvud- och halscancer i Chicago, IL
10 studier för Huvud- och halscancer söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
RekryterarFas 2/3
- Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekryterarFas 2
- University of Illinois Cancer Center, Chicago
A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
RekryterarFas 2
- The University of Chicago, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekryterarFas 1/2
- University of Chicago, Chicago
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
RekryterarFas 2
- University of Chicago Comprehensive Cancer Center, Chicago
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RekryterarFas 1
- The University of Chicago, Chicago
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
RekryterarFas 2
- The University of Chicago, Chicago
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
RekryterarFas 1
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Chicago
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
RekryterarFas 1/2
- University of Illinois at Chicago, Chicago
Huvud- och halscancer-studier i andra städer
- Houston, TX30 studier
- Boston, MA22 studier
- New York City, NY21 studier
- Nashville, TN21 studier
- St. Louis, MO15 studier
- Dallas, TX12 studier
- Pittsburgh, PA11 studier
- Los Angeles, CA10 studier
- San Antonio, TX10 studier
- Baltimore, MD10 studier
- Washington, DC10 studier
- Durham, NC10 studier
Andra studier i Chicago
- Icke-småcellig lungcancer61 studier
- Bröstcancer59 studier
- Cancer (alla typer)51 studier
- Metastaserande cancer45 studier
- Prostatacancer45 studier
- Lungcancer41 studier
- Övervikt41 studier
- Äggstockscancer36 studier
- Kolorektal cancer34 studier
- Stroke34 studier
- Hjärtsvikt31 studier
- Övervikt29 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.